Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Magnetic imaging agent
Patent
1993-08-16
1995-06-06
Hollinden, Gary E.
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Magnetic imaging agent
436173, 436806, 514 12, 514 59, 5303871, 424 9341, A61B 5055
Patent
active
054220947
ABSTRACT:
.sup.19 F labelled antibodies are disclosed which are useful in methods of NMR imaging and spectroscopy. The compositions comprise a .sup.19 F-containing sensor moiety and an antibody, preferably a monoclonal antibody, and can optionally also comprise a spacer moiety to separate the sensor moiety and the antibody.
REFERENCES:
patent: 4558279 (1985-12-01), Ackerman et al.
patent: 4586511 (1986-05-01), Clark, Jr.
patent: 4612185 (1986-09-01), Dean
patent: 4631190 (1986-12-01), Shen et al.
patent: 4639364 (1987-01-01), Hoey
patent: 4640833 (1987-02-01), Tamborski et al.
patent: 4741900 (1988-05-01), Alvarez et al.
patent: 4838274 (1989-06-01), Schweighardt et al.
patent: 5068098 (1991-11-01), Schweighardt et al.
patent: 5080885 (1992-01-01), Long, Jr.
patent: 5116599 (1992-05-01), Rogers, Jr. et al.
patent: 5130119 (1992-07-01), Blaszkiewicz et al.
patent: 5141739 (1992-08-01), Jung et al.
patent: 5196348 (1993-03-01), Schweighardt et al.
patent: 5208324 (1993-05-01), Klaveness et al.
patent: 5236694 (1993-08-01), Antich et al.
Levy et al, "Synthesis and Characterization of .sup.19 F NMR Chelators for Measurement of Cytosolic Free Ca," American Journal of Physiology, 252(4):C441-C449 (1987).
Mason et al., "A Novel Editing Technique for .sup.19 F MRI: Molecule-Specific Imaging", Magnetic Resonance Imaging, 8:729-736, (19990).
Jeffrey et al., "Rapid Non-invasive Assessment of Myocardial pO2 Using .sup.19 F NMR Spectroscopy of Sequestered Perfluorocarbon Emulsion", Abstracts of the 63rd Scientific Sessions, III-685, No. 2722; Circulation, 1990, vol. 82, No. 4.
Parhami et al., "Flourine-19 Relaxation Study of Perfluoro Chemicals as Oxygen Carriers," J. Phys. Chem. 87:1928-1938 (1983).
Mason et al., Abstract, "A Non-Invasive Assessment of Myocardial Oxygen Tension," Society of Magnetic Resonance in Medicine, Ninth Annual Meeting (Aug. 18-24, 1990).
Mason et al., "Tissue Oxygenation: A Novel Determination Using .sup.19 F Surface Coil NMR Spectroscopy of Sequestered Perfluorocarbon Emulsion," Magnetic Resonance in Medicine, 18:71-79 (1991).
Berkowitz, "Quantitative Determination of the Partial Oxygen Pressure in the Vitrectomized Rabbit Eye in Vivo Using .sup.19 F NMR," Magnetic Resonance Medicine, 21:233-241 (1991).
Mason et al., Abstract, "Simultaneous Oxygen Tension and Temperature Measurements: A Novel Non-Invasive Technique", 9th International Congress of Radiation Research (1991).
Mason et al., "A Noninvasive Assessment of Myocardial Oxygen Tension: .sup.19 F NMR Spectroscopy of Sequested Perfluorocarbon Emulsion," Magnetic Resonance in Medicine, 27:310-317 (1992).
Wilson et al., "Oxygen Kinetics in Preretinal Perfluorotributylamine," Exp. Eye Res., 5:119-126 (1992).
Berkowitz et al., "Perfluorocarbon Temperature Measurements Using .sup.19 F NMR," NMR in Biomedicine, 5:65-68 (1992).
Mason et al., "Oxygen.TM.: A Novel Probe of Tissue Oxygen Tension," Biomta.,. Art. Cells & Immob Biotech., 20(2-4), pp. 929-932 (1992).
Shukla et al., "The Relationship of Oxygen Tension and Myocardial Mechanical Function: a .sup.19 F NMR Study," Abstracts from the 65th Scientific Sessions, American Heart Association, I-693, No. 2757; Oct. 1992, vol. 86, No. 4.
Mason et al., "A Novel Approach to Localized Oxygen Measurements in Tumours: .sup.19 F NMR of Sequestered Perfluorocarbon," 17th LH Gray Conference, Canterbury, England, Apr. 1992.
Riess, "Overview of Progress in the Fluorocarbon Approach to in vivo Oxygen Delivery," Biomat., Art. Cells & Immob. Biotech., 20(2-4), pp. 183-202 (1992).
Mason et al, "In Vivo Oxygen Tension and Temperature: Simultaneous Determination Using .sup.19 F NMR Spectroscopy of Perfluorocarbon," Magnetic Resonance in Medicine, 29:296-302 (1993).
Mason et al, "Tumor Oxygen Tension Gradients: New Evidence From .sup.19 F MRI of Perfluorocarbons," Abstract of Papers for the 41st Annual Meeting of Radiation Research Society and the 13th Annual Meeting of the North American Hyperthermia Society, Dallas, Tex., (Mar. 20-25, 1993).
Shukla et al, "Tumor Oxygen Tension: A Comparison of Perfluorocarbon .sup.19 F NMR Probes," Abstract of Papers for the 41st Annual Meeting of the Radiation Research Society and the 13th Annual Meeting of the North American Hyperthermia Society, Dallas, Tex., (Mar. 20-25, 1993).
Mason et al, "Tumor Oxygen Tension: Measurement Using Oxygen.TM. as a .sup.19 F NMR Probe at 4.7 T," Program and Abstracts for the 5th International Symposium on Blood Substitutes, San Diego, Calif. (Mar. 17-20, 1993).
Hees et al, "Assessment of Changes in Murine Tumor Oxygenation in Response to Nicotinamide Using .sup.19 F NMR Relaxometry of a Perfluorocarbon Emulsion," Magnetic Resonance in Medicine, 29:303-310 (1993).
"Flusol-DA 20%," Investigator's Brochure (Jun. 6, 1986).
Alliance Pharmaceutical Corp., "Publication Information" (Sep. 30, 1992).
Taylor et al, ".sup.19 F-Nuclear Magnetic Resonance: Measurements of [O.sub.2 ] and pH in Biological Systems," Biophys. Journal, 53:227-233 (Feb., 1988).
Fishman et al, "Oxygen-Sensitive .sup.19 F NMR Imaging of the Vascular System In Vivo," Magnetic Resonance Imaging, 5:279-285 (1987).
Babcock et al, "Effect of Homonuclear J Modulation on .sup.19 F Spin-Echo Images," Magnetic Resonance in Medicine 17:179-188 (1991).
Mason et al, "A Novel Editing Technique for .sup.19 F MRI: Molecule-Specific Imaging," Magnetic Resonance Imaging 8:729-736 (1990).
Mason et al, "Perfluorocarbon Imaging In Vivo: A .sup.19 F MRI Study in Tumor-Bearing Mice," Magnetic Resonance Imaging 7:475-485 (1989).
Mason et al, "Fluorinated Polymeric Molecular Probes for Non-Invasive Assessment of pH by Magnetic Resonance Spectroscopy," Abstract form, The Society of Nuclear Medicine 39th Annual Meeting, Los Angeles, Calif. (Jun. 9-12, 1992).
Mehta et al, "Novel Fluorinated Polymeric Molecular Probes for F-19 Magnetic Resonance Imaging: Syntheses & Characterization of Fluorinated Biopolymers," Abstract Pap. Am. Chem. Soc., 202:102 (1991).
Mason et al, "In Vivo Oxygen Tension and Temperature: Stimulaneous Determination Using .sup.19 F NMR Spectroscopy of Perfluorocarbon," 1991, Society of Magnetic Resonance in Medicine.
Mehta et al, "New .sup.19 F Magnetic Resonance Imaging Agents for Drug Targeting," Proceedings of the 38th Annual Meeting 32:5, No. 731 (May 1991).
Derwent Abstract No. 73-33347u (Meito Sangyo Company, Ltd.). (1973).
Miura et al, "8-Fluoro-8-Demethylriboflavin as a .sup.19 F-Probe for Flavin-Protein Interaction. A .sup.19 F NMR Study with Egg Whit Riboflavin Binding Protein," Biochemical and Biophysical Research Communications, 110:2, pp. 406-411 (Jan. 27, 1983).
Ratner et al, ".sup.19 F Magnetic Resonance Imaging of the Reticuloendothelial System," Magnetic Resonance in Medicine, 5:548-554 (1987).
Ratner et al, "Detection of Tumors with .sup.19 F Magnetic Resonance Imaging," Invest. Radiol., 23:361-364 (1988).
Taylor et al, "Fluorinated .alpha.-Methylamino Acids as .sup.19 F NMR Indicators of Intracellular pH," Biophys. Journal, 43:261-267 (Sep. 1983).
Deutsch et al, "Intracellular pH as Measured by .sup.19 F NMR.sup.a," Annals New York Academy of Sciences, 508:33-47 (1987).
Metcalfe et al, "Free cytosolic Ca.sup.2+ Measurements with Fluorine Labelled Indicators Using .sup.19 FNMR," Cell Calcium, 6:183-195 (1985).
Smith et al, "Design of an Indicator of Intracellular Free Na.sup.+ Concentration Using .sup.19 F-NMR," Biochimica et Biophysica Acta, 889:72-73 (1986).
Evers et al, "The Potency of Fluorinated Ether Anesthetics Correlates With Their .sup.19 F Spin-Spin Relaxation Time in Brain Tissue," Biochemical and Biophysical Research Communications, 151:3, pp. 1039-1045 (Mar. 30, 1988).
Hull et al, "Chain-Fluorinated Polyamines as Tumour Markers," NMR in Biomedicine, 1:1, pp. 11-19 (1988).
Shimizu et al, "Tumor Imaging with Anti-CEA Antibody Labeled .sup.19 F Emulsion," Magnetic Resonance in Medicine, 5:290-295 (1987).
Shimizu et al, "Tumor Imaging with Anti-CEA Antibody Labeled .sup.19 F Emulsion," Magnetic Resonance in Medicine, 5:290-295 (1987).
Levy et al, "The Trifluoroacetylation of Insulin," Biochimica et Biophysica Acta, 310:398-405 (1973).
Wolfrom
Antich Peter P.
Kulkarni Padmakar
Board of Regents , The University of Texas System
Hollinden Gary E.
LandOfFree
.sup.19 F labelled antibodies and fragments thereof as NMR imagi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with .sup.19 F labelled antibodies and fragments thereof as NMR imagi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and .sup.19 F labelled antibodies and fragments thereof as NMR imagi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-985680